A review: Intraperitoneal cisplatin in the management of patients with ovarian cancer
- 31 January 1990
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 36 (1) , 1-6
- https://doi.org/10.1016/0090-8258(90)90099-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cisplatin and nifedipine: Synergistic cytotoxicity against murine solid tumors and their metastasesCancer Letters, 1986
- VP-16 and cisplatin as first-line therapy for small-cell lung cancer.Journal of Clinical Oncology, 1985
- Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.Journal of Clinical Oncology, 1985
- Etoposide salvage therapy for refractory germ cell tumors: an updateCancer Treatment Reviews, 1982
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- The effect of volume on the distribution of substances instilled into the peritoneal cavityGynecologic Oncology, 1978
- Transport of Model Compounds across the Peritoneal Membrane in the RatPharmacology, 1978
- Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivativesPublished by Elsevier ,1975
- Treatment of Ovarian Carcinoma: Possibilities for ProgressNew England Journal of Medicine, 1972
- Hemisulfur Mustard in the Palliation of Patients with Metastatic Ovarian CarcinomaObstetrics & Gynecology, 1959